Development of a selective peptide antagonist for the human natriuretic peptide receptor-B

Peptides

Volumn 26, Issue 3, 2005, Pages 517-524

  Deschênes, Julie ^a   Duperé, Cécile ^a   McNicoll, Normand ^a   L'Heureux, Nicholas ^b   Auger, François ^b   Fournier, Alain ^c   Léan, André De ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Blood pressure; Guanylyl cyclase coupled receptors; Natriuretic peptides; Phage display

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE ANTAGONIST; GLYCYLLEUCYLSERYLLYSYLGLYCYLCYSTEINYLPHENYLALANYLGLYCYLARGINYLSERYLLEUCYL ASPARTYLARGINYLISOLEUCYLGLYCYLSERYLLEUCYLSERYLGLYCYLLEUCYLGLYCYLCYSTEINYL ASPARAGINYLSERINE; GLYCYLLEUCYLSERYLLYSYLGLYCYLCYSTEINYLPHENYLALANYLGLYCYLARGINYLSERYLLEUCYL ASPARTYLARGINYLISOLEUCYLGLYCYLSERYLLEUCYLSERYLGLYCYLLEUCYLGLYCYLCYSTEINYL ASPARAGINYLSERYLPHENYLALANINE; NATRIURETIC PEPTIDE TYPE C; PEPTIDE HORMONE ANTAGONIST; PEPTIDE LIBRARY; SERYLLEUCYLARGINYLARGINYLSERYLSERYLCYSTEINYLPHENYLALANYLTHREONYLARGINYL SERYLLEUCYLASPARTYLARGINYLISOLEUCYLARGINYLSERYLLEUCYLSERYLGLYCYLLEUCYLGLYCYL CYSTEINYLASPARAGINYLSERYLPHENYLALANYLARGINYLTYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; BLOOD PRESSURE; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CLONING, MOLECULAR; COS CELLS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; NATRIURETIC AGENTS; NERVE TISSUE PROTEINS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, PEPTIDE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; UMBILICAL VEINS;

EID: 12344300566     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.10.017     Document Type: Article

References (31)

1. V. Bodart, W.E. Rainey, A. Fournier, H. Ong, and A. De Lean The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis Mol Cell Endocrinol 118 1996 137 144
2. D. Cohen, G.Y. Koh, L.N. Nikonova, J.G. Porter, and T. Maack Molecular determinants of the clearance function of type C receptors of natriuretic peptides J Biol Chem 271 1996 9863 9869
3. B.C. Cunningham, D.G. Lowe, B. Li, B.D. Bennett, and J.A. Wells Production of an atrial natriuretic peptide variant that is specific for type A receptor EMBO J 13 1994 2508 2515
4. A. De Lean, K. Racz, N. McNicoll, and M.L. Desrosiers Direct beta-adrenergic stimulation of aldosterone secretion in cultured bovine adrenal subcapsular cells Endocrinology 115 1984 485 492
5. A. De Lean, G. Thibault, N.G. Seidah, C. Lazure, J. Gutkowska, and M. Chretien Structure-activity relationships of atrial natriuretic factor (ANF) III. Correlation of receptor affinity with relative potency on aldosterone production in zona glomerulosa cells Biochem Biophys Res Commun 132 1985 360 367
6. A. DeLean, P.J. Munson, and D. Rodbard Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves Am J Physiol 235 1978 97 102
7. R. Fenrick, K. Babinski, N. McNicoll, M. Therrien, J. Drouin, and A. De Lean Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype Mol Cell Biochem 137 1994 173 182
8. M. Furuya, Y. Tawaragi, Y. Minamitake, Y. Kitajima, K. Fuchimura, and S. Tanaka Structural requirements of C-type natriuretic peptide for elevation of cyclic GMP in cultured vascular smooth muscle cells Biochem Biophys Res Commun 183 1992 964 969
9. N. Hama, H. Itoh, G. Shirakami, S. Suga, Y. Komatsu, and T. Yoshimasa Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients Biochem Biophys Res Commun 198 1994 1177 1182
10. X. He, D. Chow, M.M. Martick, and K.C. Garcia Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone Science 293 2001 1657 1662
11. H. Jin, B. Li, B. Cunningham, J. Tom, R. Yang, and P. Sehl Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats J Clin Invest 98 1996 969 976
12. C. Jossart, M. Coupal, N. Mc Nicoll, A. Fournier, B. Wilkers, A. De Lean, Photolabeling study of the ligand binding domain of natriuretic peptide receptir-A: development of a model. Biochemistry, in press.
13. K.J. Koller, and D.V. Goeddel Molecular biology of the natriuretic peptides and their receptors Circulation 86 1992 1081 1088
14. K.J. Koller, D.G. Lowe, G.L. Bennett, N. Minamino, K. Kangawa, and H. Matsuo Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP) Science 252 1991 120 123
15. J. Labrecque, J. Deschenes, N. McNicoll, and A. De Lean Agonistic induction of a covalent dimer in a mutant of natriuretic peptide receptor-A documents a juxtamembrane interaction that accompanies receptor activation J Biol Chem 276 2001 8064 8072
16. B. Li, J.Y. Tom, D. Oare, R. Yen, W.J. Fairbrother, and J.A. Wells Minimization of a polypeptide hormone Science 270 1995 1657 1660
17. K.A. Lucas, G.M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, and S. Schulz Guanylyl cyclases and signaling by cyclic GMP Pharmacol Rev 52 2000 375 414
18. S. Meloche, N. McNicoll, B. Liu, H. Ong, and A. De Lean Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amiloride Biochemistry 27 1988 8151 8158
19. R.B. Merrifield Solid-phase peptide syntheses Endeavour 24 1965 3 7
20. M. Mimeault, A. Fournier, J. Fethiere, and A. De Lean Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype Mol Pharmacol 43 1993 775 782
21. Y. Morishita, T. Sano, K. Ando, Y. Saitoh, H. Kase, and K. Yamada Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor Biochem Biophys Res Commun 176 1991 949 957
22. J.A. Norman, D. Little, M. Bolgar, and G. Di Donato Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry Biochem Biophys Res Commun 175 1991 22 30
23. Y. Ohyama, K. Miyamoto, Y. Morishita, Y. Matsuda, Y. Saito, and N. Minamino Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist Biochem Biophys Res Commun 189 1992 336 342
24. H. Poirier, J. Labrecque, J. Deschenes, and A. DeLean Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A Biochem J 362 2002 231 237
25. L.R. Potter, and T. Hunter Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation J Biol Chem 276 2001 6057 6060
26. G. Sarkar, and S.S. Sommer The "megaprimer" method of site-directed mutagenesis Biotechniques 8 1990 404 407
27. M. Silberbach, and C.T. Roberts Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation Cell Signal 13 2001 221 231
28. G. Stoupakis, and M. Klapholz Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure Heart Dis 5 2003 215 223
29. N. Tamura, Y. Ogawa, H. Chusho, K. Nakamura, K. Nakao, and M. Suda Cardiac fibrosis in mice lacking brain natriuretic peptide Proc Natl Acad Sci USA 97 2000 4239 4244
30. S. Toki, Y. Morishita, T. Sano, and Y. Matsuda HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells Neurosci Lett 135 1992 117 120
31. B. Wedel, and D. Garbers The guanylyl cyclase family at Y2K Annu Rev Physiol 63 2001 215 233